Search Results - "Tebaibia, A."

Growth Hacking: A Modern Marketing Approach For Rapid Growth Of Start-Ups In The Digital Era (Case Study Of The Algerian Start-Up Yassir).

Authors: Benmehdi, Safia Salima, Tebaibia Fatiha, Bouhrine et al.

Source: Educational Administration: Theory & Practice. 2024, Vol. 30 Issue 11, p503-510. 8p.

Innovation in the Expanded Marketing Mix and Its Role in Enhancing Marketing Performance in Hotel Establishments: A Case Study of Sheraton Hotel - Annaba-.

Authors: Mekersi, Sana Tebaibia, Salima

Source: AL-afaq Journal of Economic Studies / Revue Al-afak Des Études Économiques. 2025, Vol. 10 Issue 1, p198-216. 19p.

Le processus inflationniste et son impact sur l’économie algérienne.

Alternate Title: الظاهرة التضخمية وأثرها على الإقتصاد الجزائري.

Authors: salima, Tebaibia Nabila, Lakhal

Source: REMAH Journal. nov2020, Issue 48, p321-340. 20p.

DXA-derived visceral adipose tissue reference values and metabolic syndrome risk threshold in an Algerian adult population.

Authors: Bestaoui, Mohammed Hadi Lounici, Ali Tebaibia, Amar et al.

Source: PLoS ONE. 9/9/2025, Vol. 20 Issue 9, p1-17. 17p.

The Role Of Corporate Communication In Enhancing The Performance Of The Human Resource From The Employees' Point Of View.

Authors: Safa, Mebarki Sarra, Amroun Bilel, Merabet et al.

Source: Journal of Namibian Studies; 2023, Vol. 37, p959-975, 17p

EE475 Economic Burden on Diabetes and Cardiovascular Disease: Real World Data and Empirical Analysis in Algeria.

Authors: Tebaibia, A. Mammeri, A. Hamrour, F. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS142-S142. 1p.

EPH40 Characteristics of COVID-19 Patients Admitted to the University Hospital of El Biar in Algiers during the First 6 Months of the Epidemic in Algeria: Descriptive Study of 1008 Cases.

Authors: Tebaibia, A Mammeri, A Brahimi, H et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS441-S442. 2p.

EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic.

Authors: Tebaibia, A Mammeri, A Brahimi, H et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS434-S434. 1p.

Facteurs prédictifs de la cicatrisation muqueuse sous régime sans gluten au cours de la maladie cœliaque.

Authors: Tagzout, D. Tebaibia, A. Oumnia, N. et al.

Source: Revue de Médecine Interne. Dec2019 Supplement 2, Vol. 40, pA137-A138. 2p.

Cirrhose hépatique au cours de la maladie cœliaque : prévalence, caractéristiques et évolution sous régime sans gluten.

Authors: Tagzout, D. Tebaibia, A. Oumnia, N. et al.

Source: Revue de Médecine Interne. Dec2019 Supplement 2, Vol. 40, pA137-A137. 1p.

Diagnostic histologique de l'infection à Helicobacter pylori : prévalence et aspects histo-pathologiques.

Authors: Tagzout, D. Tebaibia, A.

Source: Revue de Médecine Interne. Dec2019 Supplement 2, Vol. 40, pA136-A136. 1p.

SFP-P146 – Pédiatrie générale et sociale – Méga-œsophage de l’enfant : profil clinique et résultats thérapeutiques

Authors: Alhallak, S. Tebaibia, A.

Source: Archives de Pédiatrie. May2008, Vol. 15 Issue 5, p986-987. 2p.

Covid 19 et maladies systémiques, le pronostic n'est pas plus mauvais : étude prospective.

Authors: Mammeri, A. Aitsaid, N. Tebaibia, A.

Source: Revue du Rhumatisme. 2023 Supplement 1, Vol. 90, pA229-A229. 1p.

Proposal of a new diagnostic algorithm for adult-onset Still's disease.

Authors: Daghor-Abbaci, Karima Ait Hamadouche, Nadia Makhloufi, Chafia Dahou et al.

Source: Clinical Rheumatology. Apr2023, Vol. 42 Issue 4, p1125-1135. 11p.

Impact of fasting on the metabolic balance of diabetic patients.

Authors: Hakem, D. Lebdjiri, M. Khdairia, I. et al.

Source: Diabetes Research & Clinical Practice. 2025 Supplement 1, Vol. 230, pN.PAG-N.PAG. 1p.

Changes in metabolic markers during Ramadan according to the IDF-DAR risk score in diabetics patients.

Authors: Malek, R. Nechadi, A. Nourredine, M. et al.

Source: Diabetes Research & Clinical Practice. 2025 Supplement 1, Vol. 230, pN.PAG-N.PAG. 1p.

A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation.

Authors: Giorgino, Francesco Taybani, Zoltán Cheng, Alice et al.

Source: Diabetes Research & Clinical Practice. Nov2025, Vol. 229, pN.PAG-N.PAG. 1p.

Maladie cœliaque et atteinte oculaire : y a-t-il un lien ?

Authors: Khalef, E. Slimani, N. Grine, S. et al.

Source: Revue de Médecine Interne. 2024 Supplement 2, Vol. 45, pA565-A566. 2p.

Efficacité et innocuité du rituximab dans la fibrose cutanée de la sclérodermie systémique diffuse à anti-topoisomérases : à propos de 3 observations.

Authors: Slimani, N. Lebdjiri, M. Grine, S. et al.

Source: Revue de Médecine Interne. 2024 Supplement 2, Vol. 45, pA538-A539. 2p.

Particularités de la sclérodermie systémique chez l'homme.

Authors: Slimani, N. Benmediouni, F. Hadjene, L. et al.

Source: Revue de Médecine Interne. 2024 Supplement 2, Vol. 45, pA532-A532. 1p.